|
|
 |
|
Viewing report
|
|
|
Allergic Rhinitis Market Forecast
Datamonitor, Dec 2010
2009 allergic rhinitis sales are estimated at $5 billion in the seven major markets, and a decline to $4 billion is forecast by 2019. The greatest threat to the market is generics, with drug classes having differing vulnerability to generic erosion. While the symptomatic treatment sales will decrease, immunotherapy sales are on the rise, with changing regulations dictating development
Reasons to Purchase
- Understand allergic rhinitis market trends, including life cycle management, current sales, and a 10 year sales forecast of symptomatic treatments
- Gain insight into the immunotherapy market and access patient based forecasts of three key immunotherapy products, with interactive assumptions
- Assess analysis of key companies in the market and see how allergic rhinitis contributes to total brand sales
|
|
|
|
